Effectiveness of Mass Oral Cholera Vaccination in Beira, Mozambique | Zendy

Marcelino Lucas | Zendy; Jacqueline Deen | Zendy; Lorenz von Seidlein | Zendy; Xuan-Yi Wang | Zendy; Julia S. Ampuero | Zendy; Mahesh Puri | Zendy; Mohammad Ali | Zendy; M. Ansaruzzaman | Zendy; Juvenaldo Amos | Zendy; Arminda Macuamule | Zendy; Philippe Cavailler | Zendy; Philippe J. Guérin | Zendy; Claude Mahoudeau | Zendy; Pierre Kahozi-Sangwa | Zendy; ClaireLise Chaignat | Zendy; Avertino Barreto | Zendy; Francisco Songane | Zendy; John D. Clemens | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effectiveness of Mass Oral Cholera Vaccination in Beira, Mozambique

Author(s) -

Marcelino Lucas,

Jacqueline Deen,

Lorenz von Seidlein,

Xuan-Yi Wang,

Julia S. Ampuero,

Mahesh Puri,

Mohammad Ali,

M. Ansaruzzaman,

Juvenaldo Amos,

Arminda Macuamule,

Philippe Cavailler,

Philippe J. Guérin,

Claude Mahoudeau,

Pierre Kahozi-Sangwa,

ClaireLise Chaignat,

Avertino Barreto,

Francisco Songane,

John D. Clemens

Publication year - 2005

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa043323

Subject(s) - cholera vaccine , medicine , cholera , vaccination , diarrhea , population , immunization , regimen , vaccine efficacy , immunology , pediatrics , virology , environmental health , vibrio cholerae , antibody , biology , bacteria , genetics

New-generation, orally administered cholera vaccines offer the promise of improved control of cholera in sub-Saharan Africa. However, the high prevalence of human immunodeficiency virus (HIV) infection in many cholera-affected African populations has raised doubts about the level of protection possible with vaccination. We evaluated a mass immunization program with recombinant cholera-toxin B subunit, killed whole-cell (rBS-WC) oral cholera vaccine in Beira, Mozambique, a city where the seroprevalence of HIV is 20 to 30 percent.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research